Cerity Partners LLC Acquires 10,062 Shares of CME Group Inc. $CME

Cerity Partners LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 7.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 137,389 shares of the financial services provider’s stock after acquiring an additional 10,062 shares during the quarter. Cerity Partners LLC’s holdings in CME Group were worth $37,519,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. SG Americas Securities LLC grew its position in CME Group by 345.2% in the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after acquiring an additional 184,459 shares during the last quarter. Dover Advisors LLC grew its position in CME Group by 95.5% in the third quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock valued at $1,512,000 after acquiring an additional 2,734 shares during the last quarter. FLC Capital Advisors bought a new position in CME Group in the fourth quarter valued at about $2,122,000. NEOS Investment Management LLC grew its position in CME Group by 32.5% in the third quarter. NEOS Investment Management LLC now owns 50,977 shares of the financial services provider’s stock valued at $13,773,000 after acquiring an additional 12,503 shares during the last quarter. Finally, Lansforsakringar Fondforvaltning AB publ grew its position in CME Group by 1.6% in the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 114,411 shares of the financial services provider’s stock valued at $30,913,000 after acquiring an additional 1,777 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 44,044 shares of company stock worth $13,297,507 over the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $263.80 on Thursday. The business’s 50 day simple moving average is $286.00 and its 200 day simple moving average is $288.28. CME Group Inc. has a one year low of $244.56 and a one year high of $329.16. The stock has a market capitalization of $95.59 billion, a PE ratio of 22.51, a PEG ratio of 2.86 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the prior year, the business posted $2.80 earnings per share. The firm’s revenue was up 14.5% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.0%. CME Group’s dividend payout ratio is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
• Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
• Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
• Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
• Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. The Goldman Sachs Group decreased their target price on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Barclays decreased their target price on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Weiss Ratings restated a “buy (a-)” rating on shares of CME Group in a report on Friday, May 29th. Finally, Rothschild & Co Redburn reduced their price target on CME Group from $340.00 to $316.00 and set a “neutral” rating on the stock in a report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $305.29.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.